This Pre-Solicitation opportunity from Department Of Defense was posted on May 27, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Notice of Intent to Sole Source Cost-Per-Result-Reportable Automated Hematology Analyzer System for Naval Medical Center Portsmouth
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The Government intends to award a sole source Firm-Fixed-Price contract to Sysmex America, Inc. for the supply of the Cost-Per-Result-Reportable (CPRR) Automated Hematology Analyzer System, specifically the XN-9100-202 model, which is uniquely equipped with fluorescent flow cytometry technology. This system offers advanced analysis capabilities by examining RNA, DNA content, and intracellular structures, enhancing the differentiation of white blood cell populations and improving the detection of immature and abnormal cells. These technological advantages lead to greater accuracy and efficiency in laboratory results, reducing manual smear reviews, and supporting early clinical decisions, which ultimately benefit patient care quality and safety. An additional unique feature is the RU 20 reagent dilution unit that minimizes reagent changes, storage needs, and workload, which is particularly valuable given the current space constraints and staffing challenges at the Naval Medical Center Portsmouth's laboratory. The contract will cover a base performance period from July 1, 2026, to June 30, 2027, with four one-year options and one optional six-month extension, and has a total estimated value of approximately $1.89 million. Market research confirmed Sysmex America, Inc. as the sole viable source due to their Federal Supply Schedule contract valid through August 2029. The Government seeks responses only if there is clear and convincing evidence that competitive procurement would be advantageous without being cost- or time-prohibitive or detrimental to the mission objectives. This notice is not a solicitation for quotes or proposals but a request for information that will inform the Government's decision on whether to proceed with sole sourcing. The points of contact for questions are Lisa Wilk and Carol Uebelacker, with responses due by June 11, 2026.
General Info
Agency
NAICS
Place of Performance
Portsmouth, VA, 23708, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
The Government hereby submits a notice of intent to award a sole source Firm-Fixed-Price contract to Sysmex America, INC. for commercial-off-the-shelf (COTS) Cost-Per-Result-Reportable (CPRR) Automated Hematology Analyzer System. The contract will consist of a base year and four (4) option years, and one (1) Optional six (6) Month Option; the period of performance for the base year is 01July2026 - 30June2027. Sysmex America, INC.'s XN-9100-202 is the only source available that utilizes fluorescent flow cytometry, which analyzes RNA and DNA content and intracellular cellular structures rather than relying solely on impedance and light scatter. This technology provides superior differentiation of white blood cell populations and improves identification of immature and abnormal cells, including blasts, atypical lymphocytes, and immature granulocytes. These capabilities support higher flagging accuracy, reduced manual smear reviews, and earlier clinical decision-making, directly impacting patient care quality and safety. Another feature is the RU 20 reagent dilution unit that has reduced diluent changes, inventory and storage. The RU is unique to Sysmex and offered by no other vendor. These features not only reduce the manual workload on minimal undermanned laboratory staff and minimal storage area needed, but increases, accuracy, efficiency, and readiness for regulatory audits within space constraints due to delays in renovation for NMCP’s laboratory. The total estimated value is $1,891,450.00. Market research has determined that Sysmex America, INC. has a strategically sourced Federal Supply Schedule contract V797D-40235 for CPRR Automated Hematology Analyzer System which is valid through 31August2029. Responses to this notice must demonstrate clear and convincing evidence that competition would be advantageous to the Government, would not be cost or time prohibitive, and would not hinder the mission objective of Naval Medical Center Portsmouth. The determination not to compete this proposed contract action is solely within the discretion of the Government. Information received will normally be considered for the purposes of determining whether to conduct a competitive procurement. The Government will not be responsible for any costs incurred by responding to this notice. This is not a request for quote or proposals. Questions or comments to this Notice of Intent should be directed to Contract Specialist, Lisa Wilk at lisa.c.wilk.civ@health.mil and Contract Officer, Carol Uebelacker at carol.e.uebelacker.civ@health.mil. Please indicate in the subject of your email: Notice of Intent Question Submission 12374114.